Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Zantac’s Developer Settles Lawsuits Claiming Cancer Link

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Compensation for Damages (Law), Drugs (Pharmaceuticals), GSK PLC, Heartburn, Liability for Products, Suits and Litigation (Civil)
←One Month Old Twin Babies Who Died With Their Mother Are Youngest Known Victims Of Hurricane Helene
Trump Keeps the Tax Cut Promises Coming, Now for Americans Abroad→

More posts

  • Staff gagging clauses lifted ahead of probe into culture at data watchdog

  • Deal with EU not dependent on tuition fees agreement, Miliband says

  • Kim Kardashian Is Dressing for Team Lewis Hamilton

  • Antonelli fastest but penalty leaves Verstappen on pole

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube